Lv3
300 积分 2022-11-25 加入
2614-P: Understanding the Lived Experiences of Dosing Practices among People Living with Obesity (PwO) Using Glucagon-Like Peptide 1 Receptor Agonists (GLP-1RAs) for Weight Loss (WL): A U.S. Qualitative Study
2个月前
已关闭
2614-P: Understanding the Lived Experiences of Dosing Practices among People Living with Obesity (PwO) Using Glucagon-Like Peptide 1 Receptor Agonists (GLP-1RAs) for Weight Loss (WL): A U.S. Qualitative Study
2个月前
已关闭
2614-P: Understanding the Lived Experiences of Dosing Practices among People Living with Obesity (PwO) Using Glucagon-Like Peptide 1 Receptor Agonists (GLP-1RAs) for Weight Loss (WL): A U.S. Qualitative Study
2个月前
已关闭
Biological and mechanistic pathways of cardiometabolic multiple long-term conditions
2个月前
已完结
Irisin ameliorates obesity and insulin resistance via adipose tissue IL-33 and regulatory T cells
3个月前
已完结
Diabetes in China part 1: epidemiology and risk factors
7个月前
已完结
Mitochondrial Dynamics in Neurodegenerative Diseases: Research Hotspots and Trends from 2005 to 2025
8个月前
已完结
The past, present, and future of adipose tissue browning and aging: a review combined with bibliometrics and bioinformatics of 2527 documents published over the past four decades
8个月前
已完结
Network pharmacology analysis revealed the mechanism and active compounds of Jiao tai wan in the treatment of type 2 diabetes mellitus via SRC/PI3K/AKT signaling
1年前
已完结
Daphnetin ameliorates hepatic steatosis by suppressing peroxisome proliferator-activated receptor gamma (PPARG) in ob/ob mice
1年前
已完结
皖公网安备34019202002308
